StockData
GLAUKOS Corp logo

GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$233.08−10.17 (-4.18%)

Close on Nov 18, 2026Market cap $13.80BP/E –Yield –

Glaukos operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Glaukos's operating income for the twelve months ending Sep 30, 2026 was -$176.16M. For fiscal 2025 it was -$199.60M. The highest annual figure on record is $4.24M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$199.60M–
FY2024Dec 31, 2024-$122.37M–
FY2023Dec 31, 2023-$128.70M–
FY2022Dec 31, 2022-$82.31M–
FY2021Dec 31, 2021-$32.87M–
FY2020Dec 31, 2020-$123.55M–
FY2019Dec 31, 2019-$50.29M–
FY2018Dec 31, 2018-$13.00M–
FY2017Dec 31, 2017-$2.28M-153.8%
FY2016Dec 31, 2016$4.24M–
FY2015Dec 31, 2015-$10.30M–
FY2014Dec 31, 2014-$13.17M–
FY2013Dec 31, 2013-$14.20M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$828.00K–
Q2 FY2026Jun 30, 2026-$17.27M–
Q1 FY2026Mar 31, 2026-$19.86M–
Q4 FY2025Dec 31, 2025-$139.87M–
Q3 FY2025Sep 30, 2025-$16.37M–
Q2 FY2025Jun 30, 2025-$22.69M–
Q1 FY2025Mar 31, 2025-$20.68M–
Q4 FY2024Dec 31, 2024-$28.67M–
Q3 FY2024Sep 30, 2024-$24.66M–
Q2 FY2024Jun 30, 2024-$29.97M–
Q1 FY2024Mar 31, 2024-$39.07M–
Q4 FY2023Dec 31, 2023-$38.62M–
Q3 FY2023Sep 30, 2023-$28.01M–
Q2 FY2023Jun 30, 2023-$29.08M–
Q1 FY2023Mar 31, 2023-$32.99M-436.9%
Q4 FY2022Dec 31, 2022-$33.73M–
Q3 FY2022Sep 30, 2022-$21.61M-296.0%
Q2 FY2022Jun 30, 2022-$36.76M–
Q1 FY2022Mar 31, 2022$9.79M–
Q4 FY2021Dec 31, 2021-$17.87M–
Q3 FY2021Sep 30, 2021$11.02M–
Q2 FY2021Jun 30, 2021-$14.22M–
Q1 FY2021Mar 31, 2021-$11.81M–
Q4 FY2020Dec 31, 2020-$11.39M–
Q3 FY2020Sep 30, 2020-$12.35M–
Q2 FY2020Jun 30, 2020-$47.20M–
Q1 FY2020Mar 31, 2020-$52.61M–
Q4 FY2019Dec 31, 2019-$29.70M-1665.5%
Q3 FY2019Sep 30, 2019-$12.42M–
Q2 FY2019Jun 30, 2019-$6.24M–
Q1 FY2019Mar 31, 2019-$1.94M–
Q4 FY2018Dec 31, 2018$1.90M+256.6%
Q3 FY2018Sep 30, 2018-$6.94M-1027.4%
Q2 FY2018Jun 30, 2018-$4.25M–
Q1 FY2018Mar 31, 2018-$3.71M-1321.7%
Q4 FY2017Dec 31, 2017$532.00K+13.7%
Q3 FY2017Sep 30, 2017$748.00K–
Q2 FY2017Jun 30, 2017-$3.87M–
Q1 FY2017Mar 31, 2017$304.00K–
Q4 FY2016Dec 31, 2016$468.00K–

More Glaukos figures

See a number that looks wrong?